Kalaris Therapeutics (KLRS) Other Non Operating Income (2019 - 2026)

Kalaris Therapeutics' Other Non Operating Income history runs 8 years deep, the most recent figure standing at $977000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 406.22% year-over-year to $977000.0; the TTM figure through Mar 2026 stood at $3.5 million (up 898.02% YoY), while the FY2025 annual figure was $2.7 million, up 1362.23% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $977000.0, up from $803000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $2.8 million in Q4 2022, with the low at -$18.2 million in Q4 2023.
• The 5-year median for Other Non Operating Income is $210000.0 (2022), against an average of -$570176.5.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income sank 747.24% in 2023, then jumped 2632.26% in 2025.
• Kalaris Therapeutics' Other Non Operating Income stood at $2.8 million in 2022, then tumbled by 747.24% to -$18.2 million in 2023, then surged by 100.35% to $64000.0 in 2024, then jumped by 1154.69% to $803000.0 in 2025, then increased by 21.67% to $977000.0 in 2026.
• Business Quant data shows KLRS's Other Non Operating Income at $977000.0 in Q1 2026, $803000.0 in Q4 2025, and $847000.0 in Q3 2025.